Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer
NCT00614822
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
DRUG:
Carboplatin, Pemetrexed and Bevacizumab
Sponsor
Christiana Care Health Services
Collaborators
[object Object]